PT914440E - Vacinação com áçido nucleico contra infecções parvovirais - Google Patents

Vacinação com áçido nucleico contra infecções parvovirais Download PDF

Info

Publication number
PT914440E
PT914440E PT97920711T PT97920711T PT914440E PT 914440 E PT914440 E PT 914440E PT 97920711 T PT97920711 T PT 97920711T PT 97920711 T PT97920711 T PT 97920711T PT 914440 E PT914440 E PT 914440E
Authority
PT
Portugal
Prior art keywords
parvovirus
nucleic acid
vaccine according
dna
vaccine
Prior art date
Application number
PT97920711T
Other languages
English (en)
Portuguese (pt)
Inventor
Colpan Dr Metin
Joachim Schorr
Henry J Baker
Bruce F Smith
Original Assignee
Univ Auburn
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Auburn, Merial Ltd filed Critical Univ Auburn
Publication of PT914440E publication Critical patent/PT914440E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT97920711T 1996-04-19 1997-04-18 Vacinação com áçido nucleico contra infecções parvovirais PT914440E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96106217 1996-04-19

Publications (1)

Publication Number Publication Date
PT914440E true PT914440E (pt) 2007-02-28

Family

ID=8222693

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97920711T PT914440E (pt) 1996-04-19 1997-04-18 Vacinação com áçido nucleico contra infecções parvovirais

Country Status (10)

Country Link
US (1) US6465438B1 (enExample)
EP (1) EP0914440B1 (enExample)
JP (1) JP4117027B2 (enExample)
AU (1) AU726059B2 (enExample)
CA (1) CA2252375C (enExample)
DE (1) DE69737231T2 (enExample)
DK (1) DK0914440T3 (enExample)
ES (1) ES2283015T3 (enExample)
PT (1) PT914440E (enExample)
WO (1) WO1997040163A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
US7294338B2 (en) 1996-07-19 2007-11-13 Merial Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
EP0863151A1 (en) * 1997-02-12 1998-09-09 Akzo Nobel N.V. "Canine parvovirus dna vaccines"
CA2223029A1 (en) 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
AU753688B2 (en) * 1997-03-10 2002-10-24 Ottawa Civic Loeb Research Institute Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP1002103B1 (en) 1997-08-04 2007-10-17 Cell Genesys, Inc. A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
JP2001520170A (ja) 1997-10-16 2001-10-30 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム Ｎｆ−ａｔ３機能に関連した心肥大動物モデルと治療法
EP1035867A1 (en) * 1997-12-02 2000-09-20 Powderject Vaccines, Inc. Transdermal delivery of particulate vaccine compositions
EP1078053B1 (en) * 1998-05-14 2005-09-28 Coley Pharmaceutical GmbH METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
AU3593200A (en) 1999-02-09 2000-08-29 Powderject Vaccines, Inc. (mycobacterium tuberculosis), immunization
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7927840B2 (en) * 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
ES2890882T3 (es) * 2002-10-16 2022-01-24 Gen Probe Inc Composiciones y procedimientos para detectar el virus del Nilo occidental
CA2527756C (en) * 2003-05-15 2014-05-06 Japan Science And Technology Agency Immunostimulating agents
JP4817599B2 (ja) * 2003-12-25 2011-11-16 独立行政法人科学技術振興機構 免疫活性増強剤とこれを用いた免疫活性の増強方法
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
ES2352534T3 (es) * 2007-12-28 2011-02-21 Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts PARVOVIRUS DOTADO DE UN GENOMA ENRIQUECIDO EN CpG ÚTIL PARA EL TRATAMIENTO DEL CÁNCER.
US9550818B2 (en) 2012-04-27 2017-01-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for use of vascular endothelial growth factor antagonists
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2026827A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
ES2026826A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
WO1994017098A1 (es) 1993-01-23 1994-08-04 Inmunologia Y Genetica Aplicada, S.A. Peptidos y vacunas sinteticos contra parvovirus
US6204059B1 (en) * 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer

Also Published As

Publication number Publication date
ES2283015T3 (es) 2007-10-16
EP0914440A1 (en) 1999-05-12
DE69737231T2 (de) 2007-10-11
CA2252375C (en) 2011-12-20
EP0914440B1 (en) 2007-01-10
DE69737231D1 (de) 2007-02-22
CA2252375A1 (en) 1997-10-30
JP4117027B2 (ja) 2008-07-09
JP2000509976A (ja) 2000-08-08
WO1997040163A1 (en) 1997-10-30
AU2699497A (en) 1997-11-12
US6465438B1 (en) 2002-10-15
AU726059B2 (en) 2000-10-26
DK0914440T3 (da) 2007-05-21

Similar Documents

Publication Publication Date Title
EP0914440B1 (en) Nucleic acid vaccination for parvoviral infections
JP7548902B2 (ja) アフリカ豚熱ウイルスワクチン
RU2312676C2 (ru) Формула кошачьей вакцины
RU2319504C2 (ru) Вакцина собак против бешенства (варианты), способ вакцинации (варианты), набор для вакцинации (варианты)
ES2304787T3 (es) Vesiculovirus recombinantes y sus usos.
ES2386373T3 (es) Vacuna contra la fiebre aftosa
Schmaljohn et al. Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins
ES3034089T3 (en) Vaccine against porcine parvovirus
AU732885B2 (en) Canine parvovirus DNA vaccines
AU731706B2 (en) Recombinant viral pseudo-particles and vaccinal and antitumoral applications thereof
US6063385A (en) DNA vaccine for parvovirus
JPH10507066A (ja) ニワトリ感染性貧血ウイルスワクチン
WO1996001116A9 (en) Chicken infectious anemia virus vaccine
US20040096462A1 (en) Noval vaccine formulation consisting of dna vaccine and inactivated virus
Cheung et al. Biotechnological approach to a new foot-and-mouth disease virus vaccine
PT1721982E (pt) Ácidos nucleicos e polipéptidos quiméricos de lissavírus
EP0863151A1 (en) "Canine parvovirus dna vaccines"
ES2358733T3 (es) Vacuna derivada de levadura contra ipnv.
Doel Modern trends in veterinary vaccinology
RABIES RECOMBINANT CANINE HERPESVIRUSES